Primo Pup LLC – Trademark Portfolio

Entity Type: 16

Primo Pup LLC holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 6 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 2 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include PRIMO PUP, PRIMO VET, PRIMO PURR, and PRIMO ANIMAL HEALTH. The owner is based in Phoenix, AZ.

Suite 106

4425 E Agave Rd

Phoenix, AZ 85044

6 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Primo Pup LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (6 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

3
Cosmetics & Cleaning (3 filings)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

Frequently Asked Questions

How many trademarks does Primo Pup LLC have?

Primo Pup LLC has 6 U.S. trademarks filed with the USPTO. Of these, 4 registered, 1 cancelled.

What trademark classes does Primo Pup LLC file in?

Primo Pup LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Primo Pup LLC's most well-known trademarks?

Primo Pup LLC's registered trademark portfolio includes well-known marks such as PRIMO PUP, PRIMO VET, PRIMO PURR, and PRIMO ANIMAL HEALTH. These are among 4 currently registered trademarks in the portfolio.

What is Primo Pup LLC's trademark registration success rate?

Primo Pup LLC has a 80% trademark registration rate, with 4 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.